Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
10/2009
10/29/2009WO2009129616A1 Genetically modified human umbilical cord perivascular cells for prophylaxis against or treatment of biological or chemical agents
10/29/2009WO2009102452A3 Compositions and methods for implantation of adipose tissue and adipose tissue products
10/29/2009WO2009099719A3 Compositions and methods for the treatment of tumor of hematopoietic origin
10/29/2009WO2009097119A3 Identification of cd8+ t cells that are cd161hi and/or il18r(alpha)hi and have rapid drug efflux capacity
10/29/2009WO2009089067A3 Methods and compositions for identifying undifferentiated stem cells and assessing cell health
10/29/2009WO2009071920A3 Methods for identifying epigenetically silenced genes and novel tumour suppressor genes
10/29/2009WO2009033112A3 Highly porous, large polymeric particles and methods of preparation and use
10/29/2009US20090271896 Method for agrobacterium-mediated transformation of plants
10/29/2009US20090271895 Plants having improved growth characteristics and method for making the same
10/29/2009US20090271893 Nucleic Acid Sequences and Methods of Use for the Production of Plants with Modified Polyunsaturated Fatty Acids
10/29/2009US20090271892 Lysophosphatidic acid acyltransferase genes and uses thereof
10/29/2009US20090271884 ES Cell-Derived Mice From Diploid Host Embryo Injection
10/29/2009US20090271883 Abi1/hssh3bp1 conditional knockout mouse
10/29/2009US20090271881 Meganuclease variants cleaving a dna target sequence from a rag gene and uses thereof
10/29/2009US20090271335 Totipotent, Nearly Totipotent or Pluripotent Mammalian Cells Homozygous or Hemizygous for One or More Histocompatibility Antigent Genes
10/29/2009US20090270595 Il-1 related polypeptides
10/29/2009US20090270491 Modulation of tudor-sn expression
10/29/2009US20090270485 Cell specific replication-competent viral vectors comprising a self processing peptide cleavage site
10/29/2009US20090270484 WWOX Vectors and Uses in Treatment of Cancer
10/29/2009US20090270425 3-(dihydro-1h-pyrazolo[4,3-d]pyrimidin-5-yl)-4-propoxybenzenesulfonamide derivatives and methods of use
10/29/2009US20090270398 Compounds, Compositions and Methods Comprising Pyridazine Derivatives
10/29/2009US20090270336 Piperazine derivatives
10/29/2009US20090270333 Methods of using motilin homologs
10/29/2009US20090270326 Cell Death Inhibitor
10/29/2009US20090270325 Growth factor
10/29/2009US20090270324 Complement depletion using recombinant human c-3 derivatives
10/29/2009US20090270318 High-affinity antagonists of elr-cxc chemokines
10/29/2009US20090270316 Her-2 binding antagonists
10/29/2009US20090270268 Methods for Obtaining Immortalized Antibody Secreting Cells
10/29/2009US20090269850 containing a reduced amount of receptor-binding protein compared with the wild type; modified HVJ containing a reduced amount of HN protein
10/29/2009US20090269849 Bioreactor Apparatus
10/29/2009US20090269848 Technique for culture of mesenchymal stem cell utilizing laminin-5
10/29/2009US20090269847 Self-assembling peptide amphiphiles and related methods for growth factor delivery
10/29/2009US20090269846 Inhibitors of tyrosine kinase receptor dimerization
10/29/2009US20090269845 Pluripotent cells
10/29/2009US20090269844 Nucleic acids encoding a receptor for il-17 homologous polypeptides
10/29/2009US20090269843 Hemopexin fusion proteins
10/29/2009US20090269841 Method and system for the production of cells and cell products and applications thereof
10/29/2009US20090269840 Kinase insert domain-containing receptor (KDR) specific immunoglobulin for monitoring tumor angiogenesis
10/29/2009US20090269833 Using sterospecific carboxylesterase variant for bioremediation of pyrethroids; eliminating or reducing the concentration of a pyrethroid pesticide in a sample
10/29/2009US20090269830 Culture System and Method for Propagation of Human Blastocyst-Derived Stem Cells
10/29/2009US20090269827 Thermophilic and thermoacidophilic metabolism genes and enzymes from alicyclobacillus acidocaldadarius and related organisms, methods
10/29/2009US20090269811 Il-1 related polypeptides
10/29/2009US20090269807 Compositions and Methods for the Expression of Selenoproteins in Eukaryotic Cells
10/29/2009US20090269802 Alpha 1,4-galactosyltransferase and dna encoding thereof
10/29/2009US20090269795 Mutant alpha4betadelta GABAA receptor and methods of treating anxiety or irritability
10/29/2009US20090269787 Monoclonal Antibody to CD166 and Method for Production Thereof
10/29/2009US20090269783 B7-H2 molecules, novel members of the B7 family and uses thereof
10/29/2009US20090269781 Single-Molecule-Format Probe And Utilization Thereof
10/29/2009US20090269763 Reprogramming a cell by inducing a pluripotent gene through RNA interference
10/29/2009US20090269755 Means and method for inducing exon-skipping
10/29/2009US20090269751 Dot1 histone methyltransferases as a target for identifying therapeutic agents for leukemia
10/29/2009US20090269739 Kit for detection of telomerase reverse transcriptase nucleic acids
10/29/2009US20090269586 Multimicrolamellar Collagen Membranes
10/29/2009US20090269389 ARPE-19 as a Platform Cell Line for Encapsulated Cell-Based Delivery
10/29/2009US20090269371 Process for the production of monoclonal antibodies
10/29/2009US20090269365 Immunogenic vaccinia peptides and methods of using same
10/29/2009US20090269360 Therapy
10/29/2009US20090269350 drug screening; used to identify compounds that act as agonists and antagonists and modulate the expression of the novel PGP synthase
10/29/2009US20090269349 Antigenic polypeptides
10/29/2009US20090269345 CLN248 Antibody Compositions and Methods of Use
10/29/2009US20090269342 Hemagglutinin Polypeptides, and Reagents and Methods Relating Thereto
10/29/2009US20090269338 Humanized anti-factor d antibodies and uses thereof
10/29/2009US20090269332 Human diacylglycerol acyltransferase 2 (DGAT2) family members and uses therefor
10/29/2009US20090269326 nucleic acid molecule which codes for 6-O-sulfatase or N-sulfamidase; degrading monosaccharides or polysaccharides with the molecules; degrading glycosaminoglycan
10/29/2009US20090269320 Variants of pigment epithelium derived factor and uses thereof
10/29/2009US20090269318 Progenitor cells from wharton's jelly of human umbilical cord
10/29/2009US20090269317 Irreversible electroporation to create tissue scaffolds
10/29/2009US20090269315 Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions
10/29/2009US20090269314 Human cardiovascular progenitor cells
10/29/2009US20090269310 Method for obtaining human smooth muscular cells and uses thereof
10/29/2009US20090269309 Retinoic acid stimulates differentiation of pancreatic progenitor cells into insulin producing cells
10/29/2009US20090269280 Method for activation of transient receptor potential cation channel, subfamily a, member 1 using acetaldehyde
10/29/2009US20090266760 Functional nucleic acids for biological sequestration
10/29/2009CA2722623A1 Treatment of pluripotent cells
10/29/2009CA2722619A1 Pluripotent cells
10/29/2009CA2722440A1 Isoprene synthase variants for improved microbial production of isoprene
10/29/2009CA2722168A1 Isoform-specific insulin analogues
10/29/2009CA2721952A1 Retinal pigment epithelial stem cells
10/29/2009CA2721870A1 Genetically modified human umbilical cord perivascular cells for prophylaxis against or treatment of biological or chemical agents
10/29/2009CA2721807A1 Transformation and engineered trait modification in miscanthus species
10/29/2009CA2721716A1 Humanized antibodies specific for amino acid sequence rgd of an extracellular matrix protein and the uses thereof
10/29/2009CA2721582A1 Recombinant deamidated gliadin antigen
10/29/2009CA2721372A1 Plant viral expression vectors and use of same for generating genotypic variations in plant genomes
10/28/2009EP2112511A1 Method of screening candidate compounds for susceptibility to biliary excretion
10/28/2009EP2112222A1 Gene encoding guanine nucleotide exchange factor and gene product thereof
10/28/2009EP2112220A2 Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences
10/28/2009EP2112166A2 Human monoclonal antibodies to CTLA-4
10/28/2009EP2112165A2 Methods and compositions for the treatment of glomerulonephritis and other inflammatory diseases
10/28/2009EP2112163A2 RGD-enriched gelatine-like proteins with enhanced cell binding
10/28/2009EP2112162A1 Genetically modified human natural killer cell lines
10/28/2009EP2112157A1 Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses
10/28/2009EP2111879A1 Bio-mimetic model systems for adjusting dissemination of cosmetic and pharmaceutical formulations onto human skin
10/28/2009EP2111748A1 Cytoplasmic male sterile rucola
10/28/2009EP2111447A1 Connective tissue repair
10/28/2009EP2111185A2 Bioerodible wraps and uses therefor
10/28/2009EP1899378B1 Il-1 beta binding antibodies and fragments thereof
10/28/2009EP1570051B1 Genetic constructs and compositions comprising rre and cte and uses thereof
10/28/2009EP1548032B9 Kdr peptides and vaccines comprising the same
10/28/2009EP1539784B1 Chitinase encoding dna molecule from cotton expressed preferentially in fibers during secondary cell wall deposition and the corresponding promoter
1 ... 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 ... 1827